脑脊液CXCL10和新蝶呤作为生物标志物在接受类固醇治疗的人类嗜T淋巴细胞病毒1型相关脊髓病/热带痉挛性截瘫中的应用 - Suppr | 超能文献

相似文献

1

Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.脑脊液CXCL10和新蝶呤作为生物标志物在接受类固醇治疗的人类嗜T淋巴细胞病毒1型相关脊髓病/热带痉挛性截瘫中的应用

J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):321-323. doi: 10.1136/jnnp-2019-321955. Epub 2019 Oct 29.

2

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.多中心、随机、双盲、安慰剂对照 3 期研究莫格利珠单抗联合最小数量人类 T 细胞白血病病毒 1 型相关脊髓病患者的开放标签扩展研究。

J Neurol. 2024 Jun;271(6):3471-3485. doi: 10.1007/s00415-024-12239-x. Epub 2024 Mar 2.

3

CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.脑脊液 CXCL10、CXCL9 和新蝶呤作为 HTLV-1 相关脊髓病/热带痉挛性截瘫的候选预后生物标志物。

PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2479. doi: 10.1371/journal.pntd.0002479. eCollection 2013.

4

Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.来自巴西亚马逊地区的人类嗜T淋巴细胞病毒I型（HTLV-I）无症状携带者及HTLV-I相关脊髓病/热带痉挛性截瘫患者的临床和实验室特征

Rev Inst Med Trop Sao Paulo. 2017 Apr 3;59:e5. doi: 10.1590/S1678-9946201759005.

5

Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?脑脊液中人类嗜T淋巴细胞病毒I型（HTLV-I）前病毒载量：作为HTLV-I相关脊髓病/热带痉挛性截瘫诊断的新标准？

J Infect Dis. 2005 Jun 1;191(11):1830-4. doi: 10.1086/429962. Epub 2005 Apr 28.

6

Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy.脑脊液新蝶呤而非骨桥蛋白，是人类嗜T淋巴细胞病毒I型相关脊髓病患者治疗反应的一种有价值的生物标志物。

Intern Med. 2013;52(19):2203-8. doi: 10.2169/internalmedicine.52.0869. Epub 2012 Mar 1.

7

Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.成人T细胞白血病/淋巴瘤相关脊髓病/热带痉挛性截瘫（HAM/TSP）患者脑脊液中HTLV-I前病毒载量增加及HTLV-I Tax特异性CD8 + T细胞优先扩增。

Ann Neurol. 2001 Dec;50(6):807-12. doi: 10.1002/ana.10065.

8

Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.脑脊液中的金属蛋白酶组织抑制剂3、基质金属蛋白酶9和新蝶呤：与健康病毒携带者相比，优先存在于I型人类嗜T淋巴细胞病毒感染的神经系统疾病患者中。

AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):965-72. doi: 10.1089/08892220050058380.

9

Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.每日泼尼松治疗对人嗜 T 淋巴细胞病毒 1 相关性脊髓病/热带痉挛性截瘫进展的影响：一项多中心回顾性队列研究。

Neurotherapeutics. 2017 Oct;14(4):1084-1094. doi: 10.1007/s13311-017-0533-z.

10

HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.人类嗜T淋巴细胞病毒I型相关脊髓病：基于临床特征和实验室检查结果对213例患者的分析

J Neurovirol. 1995 Mar;1(1):50-61. doi: 10.3109/13550289509111010.

引用本文的文献

1

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.多中心、随机、双盲、安慰剂对照 3 期研究莫格利珠单抗联合最小数量人类 T 细胞白血病病毒 1 型相关脊髓病患者的开放标签扩展研究。

J Neurol. 2024 Jun;271(6):3471-3485. doi: 10.1007/s00415-024-12239-x. Epub 2024 Mar 2.

2

Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.人类 T 淋巴细胞嗜病毒 1 型感染的临床和公共卫生意义。

Clin Microbiol Rev. 2022 Apr 20;35(2):e0007821. doi: 10.1128/cmr.00078-21. Epub 2022 Feb 23.

3